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Abstract
Background: The symptoms of Clostridium difficile infection are mediated primarily by two toxins, TcdA and TcdB,
the expression of which is governed by a multitude of factors including nutrient availability, growth phase and cell
stress. Several global regulators have been implicated in the regulation of toxin expression, such as CcpA and CodY.
Results: During attempts to insertionally inactivate a putative secondary cell wall polysaccharide synthesis gene, we
obtained several mutants containing off-target insertions. One mutant displayed an unusual branched colony
morphology and was investigated further. Marker recovery revealed an insertion in mfd, a gene encoding a
transcription-coupled repair factor. The mfd mutant exhibited pleiotropic effects, in particular increased expression
of both toxin A and B (TcdA and TcdB) compared to the parental strain. Western blotting and cellular cytotoxicity
assays revealed increased expression across all time points over a 24 h period, with inactivation of mfd resulting in
at least a 10 fold increase in cell cytotoxicity. qRT-PCR demonstrated the upregulation of both toxins occurred on a
transcriptional level. All effects of the mfd mutation were complemented by a plasmid-encoded copy of mfd,
showing the effects are not due to polar effects of the intron insertion or to second site mutations.
Conclusions: This study adds Mfd to the repertoire of factors involved in regulation of toxin expression in
Clostridium difficile. Mfd is known to remove RNA polymerase molecules from transcriptional sites where it has
stalled due to repressor action, preventing transcriptional read through. The consistently high levels of toxin in
the C. difficile mfd mutant indicate this process is inefficient leading to transcriptional de-repression.
Keywords: Clostridium difficile, Toxin A, Toxin B, Transcriptional roadblock, mfd, CcpA, Transcription-repair
coupling factor
Background
Clostridium difficile is an anaerobic, spore-forming Gram-
positive pathogen that is now recognized as the leading
cause of antibiotic-associated diarrhea in health care set-
tings [1]. The incidence and apparent severity of C. difficile
infection (CDI) rose in the mid-2000s, in part due to the
circulation of strains resistant to the newer fluoroquinolone
antibiotics [2, 3]. The infectious agent is the spore [4],
which is remarkably resistant to heat, disinfectants and
antimicrobial agents. Treatment of patients with antibiotics
dramatically alters their gut microbiota [5] and this per-
turbation can cause loss of colonization resistance, allowing
indigenous and exogenous pathogens to colonize and cause
disease [6]. Under these conditions, spores of C. difficile
can germinate in the gut, and the resulting vegetative cells
proliferate in high numbers. Vegetative cells and spores are
excreted in large numbers and subsequent spore transmis-
sion can cause localized epidemics in health care settings.
The major virulence factors are two large toxins, TcdA
(toxin A) and TcdB (toxin B). All toxigenic strains produce
toxin B and a large percentage of strains also produce toxin
A [7]. These toxins have a similar structure and mode of
action; the toxins are large, multi-domain proteins encod-
ing glucoslytransferase and cysteine protease activities to-
gether with a repetitive receptor binding domain [8]. The
toxins are released from bacteria in the gut lumen and are
taken up by receptor-mediated endocytosis into enteric
cells. Recent evidence suggests that additional receptor
binding activity could be encoded within the central trans-
location domain [9]. Once internalized into vesicles, the
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cysteine protease activity is required to release the N-
terminal glucosyltransferase domain from the adjacent
protease domain, an activity dependent on cytosolic
inositol-6-phosphate [10].
The toxin genes tcdA and tcdB are encoded within a
genomic locus, PaLoc, with three other genes: tcdR, tcdE
and tcdC [11]. The regulation of toxin synthesis is complex,
with multiple forms of regulation evident. Toxin expression
is related to the growth phase of the bacterium, with
maximal expression occurring in the late-logarithmic
phase of growth [12]; a quorum sensing molecule that
may be the main mediator of this level of regulation was
recently identified [13]. The toxins are under the control of
the Gram-positive global transcriptional regulator CodY
[14, 15]. CodY binds to the promoter upstream of tcdR
[15], a gene specifying an alternative sigma factor necessary
for transcription from the tcdA and tcdB promoters, as well
as to the tcdR promoter itself [16]. CodY also regulates over
150 other genes in C. difficile, and likely functions to moni-
tor the expression of genes in response to nutrient suffi-
ciency [14]. Several environmental and nutritional factors
influence toxin expression including sub-inhibitory levels of
antibiotics, the redox potential and the amino acid content
of the medium. Spo0A, a transcriptional regulator essential
for sporulation in B. subtilis and C. difficile, negatively regu-
lates toxin production, with spo0A mutants producing
increased levels of toxins A and B in some strains of C.
difficile [4, 17]. Notably, toxins A and B are also subject to
carbon catabolite repression (CCR), their expression being
markedly reduced in the presence of rapidly metabolizable
sugars such as glucose [12]. In Gram-positive bacteria CCR
is mediated by the transcriptional regulator CcpA. Genetic
inactivation of components of the CCR signal transduction
pathway results in de-repression of toxin expression in the
presence of glucose, showing uptake of glucose is required
for toxin repression [18]. CcpA binds to genetic elements
within the C. difficile PaLoc, but recognizes sequences
distinct from those of the well characterized cre (catabolic
repression elements) sites recognized by B. subtilis CcpA.
In C. difficile, five creCD binding sites are found within the
PaLoc: two upstream of the translational start site of tcdR,
one upstream of tcdB, one inside tcdA and one inside tcdC
[18]. Finally, Clostridium difficile toxins are regulated by the
second messenger cyclic di-GMP [19]. Increased intracellu-
lar levels of cyclic di-GMP repress expression of tcdA, tcdB
and tcdR, an effect likely mediated by the alternative sigma
factor SigD. SigD directly activates tcdR expression and, as
di-GMP lowers the levels of SigD, TcdR levels fall and toxin
gene expression is reduced.
Transcription-repair coupling factor (TRCF), also known
as Mfd in bacteria (mutation frequency decline), is a highly
conserved protein that links the processes of nucleotide
excision repair and transcription elongation [20]. In E. coli
the Mfd protein is 130 kDa and consists of 8 domains with
two functional modules; an N-terminal module homolo-
gous to UvrB that recruits DNA repair proteins and a C-
terminal module that possesses ATPase-dependent DNA
translocase motor activity [21, 22]. RNA polymerase
(RNAP) molecules that stall at DNA lesions are removed
by the translocase activity of Mfd. The removal of stalled
RNAP is not confined to DNA lesions, but is applicable to
RNAP stalled for other reasons including nucleotide starva-
tion or by blockage by other DNA bound proteins such as
transcriptional repressors (reviewed in [23]). In B. subtilis, a
Tn10 insertional mutation within mfd has been shown to
partially relieve CCR at cre elements that are sufficiently
promoter distal to form transcriptional roadblocks by re-
cruitment of CcpA [24]. Similarly, Mfd inactivation in
B. subtilis partially relieves CodY-mediated transcrip-
tional repression at post-promoter sites where this
regulator can form transcriptional roadblocks that pre-
vent RNA polymerase progression [25].
In this study, we characterize an insertional mutant in
the C. difficile mfd gene. This mutant has abnormal col-
ony morphology and produces a higher level of toxins A
and B than its parent strain.
Results
As part of a study into the C. difficile cell wall, we
attempted to use a group II intron and an erythromycin
resistance marker to target and inactivate the gene
CD2775, located in a gene cluster downstream of slpA
encoding the major S-layer protein in strain 630Δerm
[26]. No insertions into CD2775 were obtained, perhaps be-
cause this gene is essential under the conditions of growth
we employed. However some erythromycin resistant mu-
tants were obtained, presumably where the group II intron
had inserted into genes containing sequences related to the
target sequence of CD2775. One of these mutants, desig-
nated 630–911 and subsequently mfd::erm (see below), had
an interesting colony morphology on BHIS agar, with col-
onies displaying a highly branched structure in comparison
to the compact colonies obtained with the wild type parent
630Δerm (data not shown). Colony morphologies were
studied further using media of a more defined composition.
On TY agar (without glucose), the mfd mutant colonies
appeared slightly smaller than the parental strain, but
on TYG agar (containing glucose) the mutant colonies
were considerably larger and displayed a highly branched
structure (Fig. 1a). Cells from cultures grown in TY or
TYG liquid cultures were examined using phase contrast
microcopy. When grown in either medium, the cells of
the mutant appeared longer than the parental strain, up to
10 μm in length and slightly more curved (Fig. 1b).
Strain 630–911 contains a defect in the mfd gene
To investigate the phenotype of the mutant further, cell
wall extracts and supernatants were prepared from cultures
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of the 630–911 (mfd) mutant and the parental strain grown
in BHIS broth and were analyzed by SDS-PAGE (Fig. 2).
No differences in the cell wall protein profiles were ap-
parent, aside from the appearance of bands at ~42 kDa
and ~116 kDa in the Δerm strain. These are the products
of cwpV, a phase variable gene that results in variable
levels of CwpV proteins in the cell wall and which under-
goes intramolecular autoproteolysis [27, 28]. However, in
the supernatants of the mfd mutant, an increased level of
a large protein of over 212 kDa was observed, which was
not seen in strain 630Δerm. Mass spectrometry of a tryptic
digest of this protein revealed it to be derived from toxin
A (TcdA; data not shown and see below).
To localize the mutation in the mutant, genomic DNA
was prepared and digested with EcoRV, ClaI or HindIII.
The digests were ligated with plasmid pBluescript
cleaved with the same enzyme and, after ligation, E. coli
transformants were selected on erythromycin to clone
the locus into which the intron and the erm gene had
inserted. Sequence analysis of plasmids revealed the
presence of the erm gene and C. difficile DNA encoding
the ORF CD3501, indicating this gene as the site where
the intron had inserted. Insertion within CD3501 between
basepairs 1412 and 1413 was subsequently confirmed by
PCR using primers flanking the insertion site, and South-
ern blot confirmed this to be the only ClosTron insertion
site (data not shown). CD3501 encodes mfd, a
transcription-repair coupling factor (TCRF) [29]. TCRFs
are widely conserved in nature and function to relieve
stalled RNA polymerase molecules at regions of DNA
damage, increasing the rate of excision of UvrABC exonu-
cleases (see Introduction).
The mfd gene is present in a region of the chromosome
containing a putative type IV pilus operon, a peptidyl tRNA
Fig. 1 Colony and cellular morphology of the C. difficile mfd mutant. a Liquid cultures (1 μl) of strains 630Δerm and the mfd mutant containing
plasmid vector alone (pMTL960) or with the mfd gene (pSEW070) as appropriate were spotted on to TY or TYG agar and grown for 3 days.
Representative colonies were photographed. Bar = 1 cm. b Cultures of parental strain 630Δerm and the mfd mutant containing pMTL960 vector
or pSEW070 were grown in TY or TYG broth and photographed under phase contrast microscopy. Bar = 5 μm
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isomerase pth and the putative chaperone prsA (Fig. 3). To
ensure that the mutant phenotype observed was not due to
a polar effect on a downstream gene, the mfd gene was
complemented by cloning the wild-type mfd gene from
strain 630Δerm in an E. coli – C. difficile shuttle vector
under control of the constitutive promoter Pcwp2 [30] to
create pSEW070. When introduced into the mfd mutant,
pSEW070 conferred a wild-type colony phenotype (Fig. 1a)
and under phase contrast microscopy the cells had the
appearance of the wild type strain, with no elongated cells
visible (Fig. 2b). When culture supernatants were analyzed
by SDS-PAGE, the >212 kDa TcdA band was no longer
visible in the complemented strain (see below) demonstrat-
ing that these phenotypes are due solely to the disruption
of mfd. Western blotting with anti-TcdA and anti-TcdB
confirmed the over-expression of TcdA and demonstrated
that TcdB was also over-expressed (see below).
The mfd mutant over-produces toxins TcdA and TcdB
The quantities of functionally active TcdA and TcdB
present in bacterial cell lysates and in culture supernatants
were determined by a cytotoxicity assay using HT29 and
Vero cells, lines that are differentially sensitive to TcdA
and TcdB, respectively [31, 32]. When applied to these cell
lines, the toxins induce cell rounding which can be scored
by enumeration of cells by microscopy. As shown in Fig. 4,
the levels of TcdA and TcdB in the mfd mutant were con-
sistently higher than in the parental strain 630Δerm at all
time points. The toxin levels observed in the mfd mutant
varied according to time point and culture conditions, but
in all cases were over 10 fold higher than the wild-type or
genetically complemented samples. Although variations in
the fold increase of cytotoxicity of the mfd mutant to the
parental control and the complemented mutant were evi-
dent, the mfd mutant consistently produced higher levels
of TcdA and TcdB throughout growth, and this was seen
in both cell lysates and in culture supernatants. Import-
antly, in the complemented mutant the levels of both
toxins were similar to the parental cells.
To further investigate the production of toxins TcdA
and TcdB by the mfd mutant, 630Δerm, the mfd mutant
and its complement containing pSEW070 were grown in
TY or TYG and toxin levels in cell lysates and in culture
supernatants analyzed by Western blotting. As shown in
Fig. 5a, a prominent band over 212 kDa was visible by
Coomassie blue staining of cell lysates of the mfd mutant
extracted at all time points. This band was identified as
TcdA (see Fig. 2). The band was not visible in the paren-
tal strain or the complemented mutant at 6 h, but was
visible in the wild-type strain and complemented mutant
at 12, 18 and 24 h, but at considerably lower intensity than
in the mfd mutant strain. In the culture supernatants, an
equivalent band was visible at 12, 18 and 24 h, but again at
all time points the intensities of the bands seen from the
mfd mutant were greater than those in the wild-type or
complemented strain. As TcdA and TcdB are known to be
co-regulated [12] and to investigate whether TcdB expres-
sion was also up-regulated in the mfd mutant, we used
Western blotting to analyse the expression of both toxins.
The results were similar to those seen by Coomassie blue
staining and showed high level expression of TcdA in the
mfd mutant compared to the wild type or complemented
Fig. 2 Cell wall proteins and culture supernatants of the mfd mutant.
Cultures were grown in BHIS broth and cell wall proteins and culture
supernatants were prepared and analyzed by 12 % SDS-PAGE. A high
molecular weight band (▶) was observed in the culture supernatant of
the mfd mutant, which was identified as toxin A. The phase variable
CwpV protein is observed in the parental Δerm culture (▷). CWP, cell
wall proteins; SN, culture supernatants; M, molecular weight markers
Fig. 3 Genome region of C. difficile 630 at the mfd locus. Downstream of mfd (CD3501) is prsA (CD3500) a putative chaperone, while upstream is
pth (peptidyl-tRNA hydrolase; CD 3502) and a multi-gene type IV pili locus (CD3503 – CD3513). All genes are transcribed in the same direction
(right to left in this diagram). CD gene numbers are given below the genetic symbols
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strains (Fig. 5b). TcdB was also detectable by Western blot-
ting (Fig. 5c). Similarly to TcdA, the levels of TcdB were
maximal in the cell lysates of the mfd mutant compared to
the parental or complemented controls. Levels of expres-
sion did not completely mirror those of TcdA, as levels
were maximal at 24 h and those at 18 h appeared lower
than at 12 h. Only at 24 h was expression of TcdB apparent
in the supernatants, and only in the mfd mutant strains.
To verify that the increased production of toxins A and
B was due to increased transcription, RNA was extracted
Fig. 4 Cytotoxicity levels of toxins A and B in the mfd mutant. Cultures of 630Δerm, the mfd mutant or the complement were grown in TY or
TYG media. Cell lysates and culture supernatants were prepared at various time points. Samples were normalized for optical density of the culture
and analyzed for the presence of toxins A and B by cytotoxicity on HT29 cells (toxin A) or Vero cells (toxin B). Panels: a bacterial lysates on Vero
cells; b bacterial supernatants on Vero cells; c bacterial lysates on HT29 cells; d bacterial supernatants on HT29 cells. Samples were standardized
by OD at point of collection. ○, 630Δerm; ■ mfd mutant;▲ complement. Data represents the mean of two biological repeats and at least two
technical repeats and error bars represent standard deviations
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from 630Δerm and the mfd mutant after 6 h growth in
either TY or TYG, and quantitative RT-PCR performed.
As shown in Fig. 6 a significant increase in transcript
levels of both tcdA and tcdB was seen in the mfd mutant
compared to 630Δerm strain when grown in TY (p ≤0.01)
or TYG (p < 0.05). This demonstrates that an increase in
toxin production is occurring on a transcriptional level in
the mfd mutant both in the presence and absence of
glucose. Overall, our results demonstrate increased ex-
pression of toxins TcdA and TcdB in the mfd mutant, and
that this is due solely to the presence of the insertional
mutation in the mfd gene.
The mfd mutant does not exhibit a pleiotropic phenotype
As TCRFs can be involved in a diversity of cellular activ-
ities [24, 25] we investigated whether our C. difficile mfd
mutant exhibited phenotypes other than the unusual
colony morphology and toxin upregulation. The growth
rates of the wild–type and mutant strains were similar,
however when grown in TY medium (Fig. 7a), the mfd
mutant ceased growth almost completely at the end of
exponential phase (at 10 h) whereas the wild type strain
and the complemented strain continued to grow for a
further 12 h (Fig. 7b). In B. subtilis, it has been reported
that inactivation of mfd results in a 40 % decrease in
sporulation efficiency compared to WT [24]. However,
in contrast to B. subtilis, the C. difficile mfd mutant did
not show a defect in sporulation (data not shown). Fi-
nally, we also investigated flagella-mediated motility, and
found no obvious defect in the mfd mutant (data not
shown).
Discussion
Our use of marker recovery revealed that an uncharacter-
ized mutation was within mfd (CD3501), encoding a TCRF
that directs the preferential repair of template strand DNA
of transcribed genes following certain types of DNA dam-
age. In other species, it is known that Mfd acts through the
combined functions of a C-terminal domain which can
interact with, and subsequently displace, stalled RNA poly-
merases and an N-terminal domain with homology to UvrB
which recruits the nucleotide excision repair machinery,
UvrABC, via interaction with UvrA [33]. Thus, with the
combined actions of these two domains, Mfd functions to
restore transcription and repair mutations before they be-
come fixed in the genome by replication. While the role of
Mfd as a repair factor is well established, it has also been
Fig. 5 Toxin A and B production in the mfd mutant. Cultures of 630Δerm (1) the mfd mutant (2) and the complemented strain (3) were grown in
TY or TYG media. Cell lysates and culture supernatants were prepared at various time points and analyzed by Coomassie Blue stained 6 % SDS-PAGE
(a) and by Western blotting using anti-toxin A (b) or anti-toxin B antibodies (c). The addition of glucose to the TY media to form TYG is indicated. The
stained bands migrating above the 212 kDa marker in panel a are presumed to be a mixture of toxin A and toxin B, as these proteins tend to
co-migrate and smear on gels
Fig. 6 Transcription of tcdA and tcdB in the mfd mutant. The rates
of transcription of tcdA and tcdB were measured by quantitative
RT-PCR in the wild type (Δerm) and the mfd mutant strain grown in TY
and TYG media. Standard error of the mean error bars are indicated
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shown to have a role in adaptive mutagenesis. In B. subtilis
the Mfd protein is important for stationary phase muta-
genesis [34] and in Campylobacter jejuni Mfd promotes
fluroquinone resistance generating mutations [35].
In Bacillus subtilis, a forward genetics screen for mu-
tants deficient in CCR isolated an mfd mutant [24]. In
this mutant, partial relief of CCR occurred for genes
with cre sites downstream of the promoter, but not those
with promoter proximal cre sites. This suggested that
these cre sites lead to RNA polymerase stalling at a road-
block, which can be relieved by Mfd. Without Mfd to re-
lease the polymerase, the RNA polymerase will in some
instances eventually overcome the roadblock as the repres-
sor protein dissociates, resulting in increased transcription
of the gene [35]. Promoter proximal sites prevent transcrip-
tion initiation and therefore do not cause RNA polymerase
to stall, requiring no involvement from Mfd. Similarly, Mfd
has been implicated in CodY-mediated repression of genes
containing downstream CodY-binding sites [25]. The ability
of the Mfd to displace RNA polymerases stalled at tran-
scriptional roadblocks makes Mfd important in maintaining
the efficacy of this type of transcriptional repressor.
How does Mfd act in controlling the level of toxin
gene expression in C. difficile? CodY and CcpA are known
repressors of toxin production and binding sites within
the PaLoc have been identified for both these proteins. It
is possible that Mfd acts by relieving RNA polymerase
molecules stalled at roadblocks created by CodY and
CcpA. This is consistent with the observed increases in
transcription, and the large increases in toxin A and toxin
B production in the mfd mutant. In our experiments we
saw only a small effect of glucose in repression of toxin
production in the wild-type cultures, which complicates
the analysis of the mfd mutant in regard to the role of
CcpA. In the C. difficile mfd mutant it is apparent that
glucose-independent de-repression occurs, as we observe
increased transcription of tcdA and tcdB and increased
production of both toxins as measured by cell cytoxicity
and Western blotting in the mfd mutant compared to the
wild type when cultures are grown in TY medium. A simi-
lar observation was made for a ccpA mutant and it was
suggested that CcpA could also act in a glucose-independ-
ent manner [36]. It is possible we are witnessing a similar
effect here. Alternatively, it is possible that relief of CodY
or other as yet unknown transcription roadblocks is also
occurring [15].
We have not been able to identify the factor responsible
for the colony morphology phenotype or the elongated
cells. However, relief of transcriptional roadblocks is cer-
tain to have impacts on genomic loci other than the
PaLoc. In contrast to B. subtilis, we did not observe a de-
fect in sporulation for the mfd mutant, adding to the many
differences observed in the sporulation pathway between
C. difficile and B. subtilis [37]. Importantly, the observed
phenotypes of the mfd mutant were complemented upon
introduction of a plasmid-encoded copy of mfd. This study
adds another layer to the regulatory network governing
toxin synthesis and secretion and is to our knowledge the
first direct implication of Mfd with toxin production and
hence virulence of this pathogen. Finally we note that an
mfd mutant could be of utility in producing increased
levels of toxins for commercial applications.
Conclusions
We have identified that a mutation in the C. difficile mfd
gene results in abnormal colony morphology and a large
increase in the production of toxins A and B. Increased
transcription of the tcdA and tcdB genes is observed,
suggesting that in the mfd mutant there is relief of tran-
scriptional repression perhaps mediated by CcpA or CodY.
Methods
Bacterial strains, plasmids and culture conditions
C. difficile strains and plasmids are described in Table 1.
Strains were grown and maintained at 37 °C in a Whitley
DG250 anaerobic workstation under anaerobic conditions
(10 % H2, 10 % CO2, 80 % N2) (D. Whitley, Yorkshire,
UK). C. difficile strains were cultured in tryptose-yeast
Fig. 7 The mfd mutant exhibits a growth defect in rich medium. Cultures of 630Δerm (○), the mfd mutant (■) and the complemented strain (▲)
were cultured in TY (a) or TYG (b) media containing 15 μg/ml thiamphenicol and their growth measured. The 630Δerm and mfd strains
contained the plasmid pMTL960 and the complemented strain the plasmid pSEW070
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(TY) medium (3 % Bacto tryptose, 2 % yeast extract), TYG
(TY supplemented with 0.5 % filter sterilized glucose) or
BHIS (3.7 % brain heart infusion, 0.5 % yeast extract and
0.1 % cysteine). For visualization of C. difficile colony
morphology 3 μl of each strain, normalized to OD 0.3, was
spotted on to TY or TYG agar, grown for 3 days and im-
aged using a Canon EOS 450D camera. For solid media,
agar was added to a final concentration of 1.5 %. For
plasmid maintenance, media were supplemented with
15 μg/ml thiamphenicol when necessary. E. coli strains
were grown in L-broth or on L-agar as described [38]
and plasmids maintained by chloramphenicol (30 μg/ml).
For visualization of C. difficile cell morphology, strains
were grown overnight in either TY or TYG and imaged
using a Nikon Eclipse E600 microscope fitted with a
Nikon DMX1200 camera.
Genetic techniques
C. difficile genomic DNA was isolated as described previ-
ously [39] and was cleaved and ligated using conventional
procedures [40]. To obtain fragments for cloning, PCR re-
actions were performed using KOD Hot Start polymerase
(Novagen) using primers as detailed below. Standard PCR
was performed using Taq polymerase (Sigma). For marker
recovery, C. difficile 630Δerm mfd::erm genomic DNA was
digested with restriction endonucleases and the fragments
cloned into pBluescript cleaved with the same enzymes.
After ligation, the products were transformed into E. coli
NovaBlue (Merck) and transformants selected on L-agar
containing 500 μg/ml erythromycin. Plasmid pSEW070
was created by amplification of the mfd gene from C.
difficile 630Δerm using KOD polymerase with primers
NF2234 and NF2298 and cloning into pMTL960 using the
BamHI and SacI sites. Plasmids were conjugated into C.
difficile firstly by transforming into E. coli CA434, select-
ing for chloramphenicol (30 μg/ml) resistance followed by
conjugation into C. difficile 630Δerm and selection for
thiamphenicol resistance (15 μg/ml) in the presence of
clycloserine (250 μg/ml) to kill the E. coli donor cells.
ClosTron mutants were created using the methods de-
scribed [41, 42]. Briefly, the L1.LtrB intron present in plas-
mid pMTL007C-E5 was retargeted to CD2775 using the
ClosTron web site (www.clostron.com) and the resulting
plasmid pSEW035 constructed by DNA2.0. pSEW035 was
transformed into E. coli CA434 and then conjugated into
C. difficile 630Δerm selecting for thiamphenicol resistance
(15 μg/ml). Thiamphenicol resistant colonies were re-
streaked on to erythromycin (5 μg/ml) to obtain colonies
containing chromosomally integrated introns.
RNA isolation
RNA for quantitative real time PCR was extracted from
630 Δerm and the mfd mutant following 6 h growth in TY
or TYG. 5 ml of culture was added to 10 ml of RNA pro-
tect (Qiagen) in the anaerobic chamber before 10 min cen-
trifugation at 5000 x g, 4 °C. RNA was purified using the
FastRNA Pro Blue kit (BIO 101 Systems) and a FastPrep-24
automated homogenizer (MP Biomedical, 45 m/s, for 3 cy-
cles), followed by DNase treatment (TURBO DNA-free,
Applied Biosystems). To verify removal of DNA, 16 S
rRNA PCR amplification was carried out with 1 μg of
RNA. 1 μg of RNA was processed using RETROscript First
Strand Synthesis Kit (Ambion).
Quantitative RT-PCR
Quantitative real time PCR was performed using SYBR
Green JumpStart Taq Ready Mix (Sigma), 50 mM of
gene specific primers (Table 2), 2 μl of cDNA obtained
from 1 μg of RNA as described above, and a Rotor-Gene
6000 real -time rotary analyzer (Corbett). SYBR® Green
reaction mixtures contained 500 nM of each primer in a
final volume of 20 μL and were incubated for ten mi-
nutes at 95 °C, 40 cycles at 95 °C for 30 s, 48 °C for 30 s,
72 °C for 60 s, and a final extension step at 72 °C for
3 min. Melting curves were performed from 50 to 99 °C
reading fluorescence at 0.5 °C intervals. Mean Ct values
Table 1 Strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source or reference
C. difficile strains
630Δerm Wild-type strain Obtained from
Peter Mullany [29]
630-911 (mfd mutant) 630Δerm mfd::ermB This study
630 tcdA tcdB 630Δerm tcdA::catP tcdB::erm Obtained from
Nigel Minton; [43]
Plasmids
pMTL960 Plasmid vector for
complementation studies
Obtained from
Nigel Minton; [38]
pSEW070 pMLT960 carrying wild
type mfd gene under
control of Pcwp2
This study
Table 2 Primers used in this study
Primer
name
Sequence (5’ to 3’) Used for
SW78 TCTACCACTGAAGCATTAC qPCR for tcdA
SW79 TAGGTACTGTAGGTTTATTG qPCR for tcdA
SW80 ACCATATAGCTTTGTGATAGTGAAGGAAA qPCR for tcdB
SW81 AAGAACTACATCAGGTAATTCAGATACAAA qPCR for tcdB
SW82 GGATGATATGATGAAGGTTAGAAACCT qPCR for rpoB
SW83 CCCAATCCAAGTTCTTCTAGTTTTTG qPCR for rpoB
NF408 TCTTGAATATCAAAGGTGAGCCAGTACA 16S RNA
amplfication
NF409 TACAGCGTGGACTACCAGGGTATCTAAT 16S RNA
amplfication
NF2234 GATCGAGCTC AATATAATGGATAGTGAGAG mfd amplication
NF2298 GATCGAGCTC AATATAATGGATAGTGAGAG mfd amplication
Willing et al. BMC Microbiology  (2015) 15:280 Page 8 of 10
were normalized to rpoB, which was amplified using
primers SW82 and SW83. Each reaction was performed
in technical duplicate and relative expression values re-
ported are representative of two biological replicates.
Western blotting and mass spectrometry
SDS-PAGE was carried out as described previously [38].
6 % or 12 % acrylamide was used in the resolving gel as
specified in the figure legends. For immunoblot analysis,
proteins were transferred to Immobilon-PVDF mem-
branes (Millipore) using a three-buffer semi-dry method
according to the instructions provided by the manufac-
turer. Anti-Toxin A (PCG4.1, Novus Biologicals) was used
in a 1:1000 dilution and rabbit anti-Toxin B (a gift from
Ingo Just, Hannover Medical School) in a 1:5000 dilution
in 3 % milk powder (VWR) in PBS (VWR). Primary anti-
bodies were detected by using horseradish peroxidase
(HRP)-conjugated goat anti-mouse antibody at 1:1000
(Dako) and the SuperSignal West Pico chemiluminescent
substrate (Thermo Scientific Pierce).
Identification of protein bands from SDS-PAGE was
by mass spectrometry carried out at the Protein and
Nucleic Acid Chemistry Facility of the University of
Cambridge, Cambridge, United Kingdom. Samples were
prepared according to the instructions given at http://
www3.bioc.cam.ac.uk/pnac/proteomics.html.
HT29 and Vero cell cytotoxicity assays
Overnight cultures of C. difficile in TY or TYG were
used to inoculate media to a starting optical density at
600 nm of 0.05. Culture supernatants and bacterial cell
lysates were collected at 6, 12, 18, and 24 h by centrifu-
gation (4000 g, 10 min, 4 °C). Supernatants were filtered
through 0.2 μm pore size units and concentrated on
3 kDa molecular weight cut-off centrifugal filters (Amicon).
Bacteria were washed once in Tris-buffered saline (10 mM
Tris.HCl, pH 7.5, 150 mM NaCl) and stored at −80 °C. Bac-
teria were re-suspended in PBS and lysed by repeated
freeze-thawing at 37 °C. Lysates were centrifuged at 20,
800 g for 5 min and the supernatant removed into a fresh
tube to obtain the soluble fraction. The preparations were
stored at −20 °C. Samples were normalized by the addition
of PBS to a final volume proportional to the optical density
of the culture at the time of collection. For both soluble cell
lysates and supernatants, an OD of 20 was diluted to a total
volume of 50 μl in PBS. Ten-fold serial dilutions of these
samples were made in PBS and 20 μl of each dilution was
added to 80 μl of fresh media above confluent HT29 or
Vero cells giving an additional 1-in-5 dilution. Cells were
incubated (37 °C, 5 % CO2) with supernatants or lysates for
24 h before scoring toxin endpoint titers by examination
using a Nikon Eclipse TS100 light microscope. Toxin end
point-titers were taken as the first dilution at which cell
morphology was indistinguishable from untreated controls.
PBS alone or supernatants prepared from an isogenic tcdA
tcdB [43] did not cause morphological changes in either cell
line.
The HT-29 line is reported as being sensitive to TcdA
in the pg range and TcdB in the mg range, whereas the
Vero line is sensitive to TcdB in the pg range and TcdA
in the ng range [32]. HT29 and Vero cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM with
4500 mg/l glucose and sodium bicarbonate) supplemented
with 10 % (v/v) fetal calf serum, 1 x non-essential amino
acids, 4 mM L-glutamine and penicillin/streptomycin
(Sigma). Confluent cell monolayers were prepared by
seeding 96 well plates with 2 x 104 cells/well followed by
72 h growth (37 °C, 5 % CO2).
Availability of supporting data
Additional data supporting the results shown and the
strains and plasmids generated in this study are available
from the authors.
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